Tumor-specific T cells and their role in tumor destruction
Author Information
Author(s): Hauke Winter, Natasja K van den Engel, Christian H Poehlein, Rudolf A Hatz, Bernard A Fox, Hong-Ming Hu
Primary Institution: Providence Portland Medical Center, Portland, Oregon, USA
Hypothesis
Can lymphotoxin-α (LT-α) act as an effector molecule of tumor-specific T cells in mediating tumor regression?
Conclusion
LT-α expression by effector T cells contributes to anti-tumor activity by stimulating tumor cells to secrete chemokines that attract macrophages.
Supporting Evidence
- Effector T cells from GKO or PKO/GKO mice showed reduced therapeutic efficacy when LT-βR signaling was blocked.
- D5 tumor cells expressed LT-βR and were stimulated to secrete chemokines by LT-α.
- Neutralization of IFN-γ significantly reduced the efficacy of LKO effector T cells.
Takeaway
The study shows that special immune cells can help fight tumors by sending signals that attract other immune cells to the tumor site.
Methodology
Effector T cells were generated from tumor vaccine-draining lymph nodes and tested for their ability to mediate regression of pulmonary metastases.
Potential Biases
Potential bias in the selection of experimental groups and the interpretation of results.
Limitations
The study primarily focused on specific signaling pathways and did not explore all potential effector mechanisms.
Participant Demographics
Mice were generally 8 to 12 weeks old at the time of experimentation.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website